DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Motzer R, Alekseev B, Rha SY. et al.
CLEAR Trial Investigators. Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma.
N Engl J Med 2021;
384 (14) 1289-1300
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.